Flu shots linked to lower AFib risk, heart study finds
Yes—flu shots are linked to a lower risk of atrial fibrillation (AFib), according to a large observational study in the European Heart Journal. Researchers also tied vaccination to lower risks of death, heart attack, and heart failure. The absolute AFib drop was modest for individuals, but authors say it may matter at the population level.
Key Takeaways
- A European Heart Journal analysis associated flu shots with lower yearly AFib rates (0.89% vs. 1.12%) after propensity matching.
- Vaccinated patients also showed lower risks of all-cause mortality, myocardial infarction, and heart failure.
- Researchers studied more than 1.1 million adults; matched groups of about 138,000 each were followed for a mean of 2.7 years.
- Authors frame influenza vaccination as part of broader cardiovascular prevention, not an AFib-only therapy.
What did the new flu shot and AFib study find?
According to Cardiovascular Business, cardiologist Laurent Fauchier, MD, PhD, of Trousseau University Hospital in Tours, France, and colleagues linked influenza vaccination to multiple heart benefits. The work was published in the European Heart Journal on July 11, 2026.
Using TriNetX Global Collaborative Network data, the team reviewed adults who had a routine healthcare visit in 2022—more than 1.1 million patients in total. Propensity score matching compared roughly 138,000 people who received a flu vaccine in the prior year with a similar group who did not.
After a mean follow-up of 2.7 years, yearly AFib rates were 0.89% among vaccinated patients and 1.12% among those not vaccinated. Flu shots were also associated with significantly lower risks of all-cause mortality, myocardial infarction, and heart failure. Benefits held across age and certain disease subgroups, the authors reported.
Why do researchers say flu shots matter for heart health?
Fauchier and colleagues wrote that evidence increasingly points beyond respiratory protection alone. Randomized trials and large observational studies have shown reductions in mortality and cardiovascular hospitalizations in high-risk groups, especially people with heart failure or established cardiovascular disease.
They argue vaccination is shifting from infectious-disease control alone toward a component of cardiovascular prevention. That framing helps explain why a modest absolute drop in incident AFib can still matter when AFib is common and vaccines have a favorable safety profile.
For readers tracking health headlines alongside entertainment and alert coverage, see more updates in our Streaming & TV Alerts section.
Should flu shots replace other AFib prevention steps?
No. The study authors caution that the absolute reduction in new AFib was modest and may look limited for any one person. They say influenza vaccination should not be treated as a targeted AFib-only intervention.
Instead, they recommend considering flu shots within comprehensive cardiovascular and AFib prevention in routine care. Even small relative risk reductions, they note, can add up at the population level.
Separately, local clinics continue promoting access: Maui Now reported Walmart will offer no-cost flu shots and free blood pressure and BMI screenings at Hawaii stores, including Kahului, from 10 a.m. to 2 p.m. Saturday as a walk-in wellness event.
What should patients ask their doctor about flu shots?
Ask whether a flu vaccine fits your overall heart-risk plan, especially if you have heart failure, prior cardiovascular disease, or other high-risk factors highlighted in the research discussion. Confirm timing, insurance coverage, and any contraindications with a clinician or pharmacist.
This coverage summarizes reporting on the Fauchier et al. observational analysis and related wellness access notes. It is not medical advice; individual decisions should follow professional guidance.